GSK buys full rights to make COVID, influenza vaccines from CureVac
Wednesday, July 3rd 2024, 6:25:52 am
article
The deal is the result of restructuring a collaboration, which began in 2020 to develop mRNA-based vaccines for infectious diseases, into a new licensing agreement, GSK added. As a result of the collaboration, the two companies have vaccine candidates for seasonal influenza and COVID-19 in phase II clinical development and avian influenza in phase I clinical development.
Breaking
The package aims to ease the burden of inflation on households and businesses, according to media report...
https://www.newsnationnow.com/cuomo-show/ufo-doc-alien-tech-coverup-dan-farah/...
It’s an exciting Conference IV showdown for the Nassau title as Seaford seeks a “revenge tour” against the group that handed the team its only 2025 loss and eliminated it in last year’s semifinals....
